This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
September 2026 quarter: consolidated revenue up 15.8%, profit after tax up 42.7% year on year
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the September 2026 quarter, consolidated revenue from operations rose 15.8% to INR 4,968.21 million from INR 4,291.91 million a year earlier; consolidated profit after tax rose 42.7% to INR 754.83 million from INR 528.90 million. Consolidated six-month revenue was INR 9,470.36 million; net profit INR 1,323.66 million; operating cash flow INR 2,226.83 million. Prior figures were restated for EQAS. Interim dividend INR 1 per share.
Profit growth, positive operating cash flow and the dividend may support the stock; the mid-year auditor change is a point to watch.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹496.8 Cr | ₹429.2 Cr | +15.8% |
| Operating profit | ₹93.99 Cr | ₹70.13 Cr | +34.0% |
| Profit after tax | ₹75.48 Cr | ₹52.89 Cr | +42.7% |
| EBITDA margin | 27.0% | 25.2% | +1.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.